The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society’s members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies.
The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT’s strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
Each year, ASGCT hosts an Annual Meeting with nearly 3,000 attendees and over 1,000 abstracts. The Scientific Program is developed by the Program, Education and Scientific Committees. The 22nd Annual Meeting of ASGCT will be held April 29 -May 2, 2019 in Wasgington, D.C. Visit https://annualmeeting.asgct.org/am19 to learn more.